Viewing Study NCT02814968


Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2026-01-24 @ 7:09 AM
Study NCT ID: NCT02814968
Status: COMPLETED
Last Update Posted: 2022-04-14
First Post: 2016-06-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide
Sponsor: The European Uro-Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer Metastatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Castration-resistant prostate cancer View
None Enzalutamide View
None Imaging View
None PET/CT View
None Whole body MRI View
None Circulating tumour cells View
None Cell-free tumour DNA View